- Home
- ZBIO vs OTLY Comparison
ZBIO vs OTLY Comparison
Compare ZBIO & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- OTLY
- Stock Information
- Founded
- ZBIO 2019
- OTLY 1994
- Country
- ZBIO United States
- OTLY Sweden
- Employees
- ZBIO N/A
- OTLY N/A
- Industry
- ZBIO
- OTLY Packaged Foods
- Sector
- ZBIO
- OTLY Consumer Staples
- Exchange
- ZBIO NYSE
- OTLY Nasdaq
- Market Cap
- ZBIO 339.3M
- OTLY 395.7M
- IPO Year
- ZBIO 2024
- OTLY 2021
- Fundamental
- Price
- ZBIO $8.40
- OTLY $0.67
- Analyst Decision
- ZBIO Strong Buy
- OTLY Buy
- Analyst Count
- ZBIO 5
- OTLY 3
- Target Price
- ZBIO $31.75
- OTLY $1.27
- AVG Volume (30 Days)
- ZBIO 371.9K
- OTLY 2.7M
- Earning Date
- ZBIO 02-16-2025
- OTLY 02-12-2025
- Dividend Yield
- ZBIO N/A
- OTLY N/A
- EPS Growth
- ZBIO N/A
- OTLY N/A
- EPS
- ZBIO N/A
- OTLY N/A
- Revenue
- ZBIO N/A
- OTLY $813,471,000.00
- Revenue This Year
- ZBIO N/A
- OTLY $7.92
- Revenue Next Year
- ZBIO N/A
- OTLY $6.69
- P/E Ratio
- ZBIO N/A
- OTLY N/A
- Revenue Growth
- ZBIO N/A
- OTLY 5.06
- 52 Week Low
- ZBIO $7.50
- OTLY $0.60
- 52 Week High
- ZBIO $26.25
- OTLY $1.40
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- OTLY 49.64
- Support Level
- ZBIO N/A
- OTLY $0.65
- Resistance Level
- ZBIO N/A
- OTLY $0.69
- Average True Range (ATR)
- ZBIO 0.00
- OTLY 0.04
- MACD
- ZBIO 0.00
- OTLY 0.00
- Stochastic Oscillator
- ZBIO 0.00
- OTLY 37.73
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.